A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- The devil is in the detail : and if the silence of Discovery was the missing piece of the puzzle? Jun 3, 2020
- Delta variant, four nurses already vaccinated with double dose infected Jul 9, 2021
- Named products that help to preserve the memory Jun 2, 2020
- Teens are very close to getting vaccinated against covid-19 May 29, 2021
- Paro Fenats: 61 surgeries have been suspended at the Regional Hospital of Concepción in 3 days Nov 11, 2022
- The use of unsuitable masks could cause deformations in children’s ears | Video May 28, 2021
- This popular product is dangerous for the brain Jul 13, 2020